Which of the following measures are used to manage bone-mineral disorders in dialysis patients?

• A. Phosphate binders
• B. Vitamin D analogs
• C. Regular calcium monitoring
• D. All of the above

Answer: (D)

Managing bone-mineral disorders in dialysis patients hinges on balancing phosphate, calcium, and parathyroid hormone through multiple strategies. Phosphate binders work by reducing intestinal phosphate absorption, helping to control hyperphosphatemia that drives bone disease and vascular calcification. Vitamin D analogs address secondary hyperparathyroidism by helping suppress excess parathyroid hormone and support bone turnover, though they require careful dosing because they can raise calcium and phosphate levels if not monitored. Regular calcium monitoring provides the essential feedback to tailor binder therapy and vitamin D dosing, keeping calcium in a safe range while guiding adjustments to maintain overall mineral balance. Because each approach targets a different part of the CKD-related bone-mineral disorder, using all of these measures together represents a comprehensive management strategy.